Syphilis and penicillin shortage: surveillance, pharmaceutical services and federal response (2014-2023) [0.03%]
梅毒和青霉素短缺：监测、药房服务及联邦应对（2014-2023）
Esdras Daniel Dos Santos Pereira,Vera Lucia Luiza
Esdras Daniel Dos Santos Pereira
Syphilis remains a significant sexually transmitted infection in Brazil, with benzathine penicillin (BPG) as the first-line treatment. In 2014, the country faced a global penicillin shortage, prompting a coordinated federal response, especi...
Two decades of the National Pharmaceutical Policy: a commitment to life [0.03%]
国家药物政策二十年——致力于生命健康事业发展
Silvana Nair Leite,Fernanda Manzini,Jorge Carlos Santos da Costa et al.
Silvana Nair Leite et al.
[This corrects the article doi: 10.1590/1413-81232025307.05232023EN].
Published Erratum
Ciencia & saude coletiva. 2026 Jan;31(1):e16022025. DOI:10.1590/1413-81232026311.16022025 2026
Specialized Component of Pharmaceutical Care: the state organization and access to medicines [0.03%]
药学保健的专门化成分：药品的组织和获取状态
Ana Liani Beisl Oliveira,Mônica Rodrigues Campos,Mareni Rocha Farias et al.
Ana Liani Beisl Oliveira et al.
This study aimed to characterize the organization of the Specialized Components of Pharmaceutical Care (Componente Especializado da Assistência Farmacêutica - CEAF) in Brazil and to categorize the different strategies as centralized or de...
Medicine accessibility in remote areas of the state of Amazonas and the challenges in implementing the PNAF [0.03%]
亚马逊州偏远地区的药品可及性以及实施PNAF的挑战
Genize Kaoany Alves Vasconcelos,Amanda Mamed de Gusmão Lobo,Rana Andressa Castelo Branco Feitosa et al.
Genize Kaoany Alves Vasconcelos et al.
The National Pharmaceutical Policy (Política Nacional de Assistência Farmacêutica - PNAF) takes regional priorities into account. In the Amazon region, social and geographic accessibility indicators are crucial for improving access and e...
Judicial access to medicines for rare diseases: characteristics of lawsuits against the Federal Government [0.03%]
罕见病的司法药物准入诉讼特征：对联邦政府的起诉案件分析
Vera Lúcia Edais Pepe,Michelly Ribeiro Baptista,Miriam Ventura et al.
Vera Lúcia Edais Pepe et al.
Rare diseases are an important cause of infant mortality, yet their care presents many challenges. Legal claims have enabled access to medicines, but there are concerns about interference in health policy and patient safety. The present stu...
Criteria used in clinical practice guidelines for the management of pharmaceutical service [0.03%]
药学服务管理临床实践指南的制订标准
Mariana Rosa Gomes,Paula Rossignoli,Fernando Fernandez-Llimos et al.
Mariana Rosa Gomes et al.
Little is known about the perception of healthcare professionals working in the management of the Specialized Component of Pharmaceutical Service (Componente Especializado da Assistência Farmacêutica - CEAF) regarding the clearness of the...
Twenty years of research in pharmaceutical services in the context of primary health care: a scoping review [0.03%]
二十年来以初级卫生保健为基础的药学服务研究：系统综述
Rafaela Tavares Peixoto,Patrícia Bernardi Sassi,Samara Jamile Mendes et al.
Rafaela Tavares Peixoto et al.
The National Pharmaceutical Policy (PNAF) is a significant milestone for pharmaceutical services (PS) within the Unified Health System (SUS). Besides defining PS, the PNAF's strategic lines highlight the need for complementary sectoral poli...
Availability of basic component medicines recommended in the PCDT in municipal lists of essential medicines [0.03%]
PCDT推荐的基层常用组分药物在城市基本药物目录中的可获得性
Beatriz de Toledo Minguzzi,Adriane Lopes Medeiros Simone,Bruna Bento Dos Santos et al.
Beatriz de Toledo Minguzzi et al.
The integrality of care is one of the core principles of the National Policy of Pharmaceutical Assistance (Política Nacional de Assistência Farmacêutica - PNAF) and underpins two tools that guide the use of medicines: clinical protocols ...
Pharmaceutical services and the incorporation of psychotropics: therapeutic gaps and opportunities to strengthen SUS [0.03%]
药学服务与精神药物的整合：加强巴西国家卫生系统(SUS)的治疗缺口和机遇
Daniela Valdivieso,Luiza Vasconcelos Biglia,Rafael Santos Santana et al.
Daniela Valdivieso et al.
This study aimed to analyze the evolution in the incorporation of psychotropics into National List of Essential Medicines (Relação Nacional de Medicamentos Essenciais - RENAME) and whether the current list meets the burden of mental disor...